Gyre Therapeutics (GYRE) EBIT Margin (QoQ) (2010 - 2026)
Gyre Therapeutics (GYRE) EBIT Margin (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Gyre Therapeutics |
548.82 Mn |
534.69 Mn |
8.38 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-1,913.00 |
| Dec 31, 2025 |
-4,507.00 |
| Sep 30, 2025 |
1,455.00 |
| Jun 30, 2025 |
-220.00 |
| Mar 31, 2025 |
792.00 |
| Dec 31, 2024 |
-1,422.00 |
| Sep 30, 2024 |
395.00 |
| Jun 30, 2024 |
-1,704.00 |
| Mar 31, 2024 |
36,723.00 |
| Dec 31, 2023 |
-37,736.00 |
| Sep 30, 2023 |
2,288.00 |
| Jun 30, 2023 |
-977.00 |
| Mar 31, 2023 |
4,886.00 |
| Mar 31, 2022 |
-101,901.00 |
| Dec 31, 2021 |
26,489.00 |
| Sep 30, 2021 |
66,180.00 |
| Jun 30, 2021 |
-22,967.00 |
| Mar 31, 2021 |
-60,184.00 |
| Dec 31, 2020 |
87,524.00 |
| Sep 30, 2020 |
-75,581.00 |
